ReviewClinical ophthalmology (Auckland, N.Z.)2015
Ocular tuberculosis: current perspectives.
Review in Clinical ophthalmology (Auckland, N.Z.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 139 citations in OpenAlex.
- Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds.International ophthalmology · 2026Review
- Are the SUN Criteria Sufficient for Tubercular Uveitis? Findings From a Multinational Registry Study.Investigative ophthalmology & visual science · 2026Observational
- Tubercular Uveitis: Multimodal Imaging, Immunologic Stratification, and a Practical Framework for Diagnosis and Management.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Tuberculous Serpiginous-Like Choroiditis, Optic Nerve Tuberculoma and Tuberculous Episcleritis: A Case Report.Clinical case reports · 2025Article
- Use of corticosteroids in non-infectious uveitis - expert consensus in Taiwan.Annals of medicine · 2024Review
- Case Report: Unveiling the Unseen - Ocular Tuberculosis Presenting as Chalazion.The American journal of tropical medicine and hygiene · 2024Article
- Article
- Characteristics and outcomes of the duration of treatment with adjunctive corticosteroids in intraocular tuberculosis.Journal of clinical tuberculosis and other mycobacterial diseases · 2024Article
- Detection of microRNAs expression signatures in vitreous humor of intraocular tuberculosis.Molecular biology reports · 2023Article
- Article
- Tuberculosis of the eye, case series study.Journal of medicine and life · 2022Article
- Commentary: Importance of ocular imaging in macular serpiginous choroiditis.Indian journal of ophthalmology · 2022Article
- Dysregulated expression of microRNAs in aqueous humor from intraocular tuberculosis patients.Molecular biology reports · 2022Article
- The Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.American journal of ophthalmology · 2021Article
- The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area.International ophthalmology · 2021Article
- Antimicrobial guide to posterior segment infections.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021Review
- Optic nerve tuberculoma in an immunocompetent patient: Case report.Radiology case reports · 2021Article
- Systemic sarcoidosis revealed by venepunctures: a very rare but rewarding cutaneous manifestation.BMJ case reports · 2020Article
- Bleb-related tuberculous endophthalmitis following combined phacoemulsification and trabeculectomy with mitomycin C.BMJ case reports · 2020Article
- Characterization of and advanced diagnostic methods for ocular tuberculosis and tuberculosis.International journal of ophthalmology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization currently estimates that nearly two billion people, or one-third of the world's population, are infected by tuberculosis, and that roughly 10% of the infected people are symptomatic. Tuberculosis affects the lungs in 80% of patients, while in the remaining 20% the disease may affect other organs, including the eye. Uveitis can be seen concurrently with tuberculosis, but a direct association is difficult to prove. Ocular tuberculosis is usually not associated with clinical evidence of pulmonary tuberculosis, as up to 60% of extrapulmonary tuberculosis patients may not have pulmonary disease. The diagnosis of tuberculous uveitis is often problematic and in nearly all reported cases, the diagnosis was only presumptive. Tuberculous uveitis is a great mimicker of various uveitis entities and it can be considered in the differential diagnosis of any type of intraocular inflammation. It is still unknown if ocular manifestations result from a direct mycobacterium infection or hypersensitivity reaction and this is reflected on the management of tuberculous uveitis. Prevalence of tuberculosis as an etiology of uveitis may reach up to 10% in endemic areas. Tuberculous uveitis is a vision-threatening disease that inevitably leads to blindness if not properly diagnosed and treated. The aim of this review is to illustrate the various clinical features and management of presumed tuberculous uveitis. The current review focuses on the diagnostic criteria, significance of tuberculin skin test, and use of systemic corticosteroids in the management of tuberculous uveitis as recommended in recent publications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.